3-172251436-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_022763.4(FNDC3B):c.685C>T(p.His229Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022763.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FNDC3B | NM_022763.4 | c.685C>T | p.His229Tyr | missense_variant | 6/26 | ENST00000415807.7 | NP_073600.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FNDC3B | ENST00000415807.7 | c.685C>T | p.His229Tyr | missense_variant | 6/26 | 1 | NM_022763.4 | ENSP00000411242.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250902Hom.: 0 AF XY: 0.0000885 AC XY: 12AN XY: 135596
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.0000426 AC XY: 31AN XY: 727222
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.685C>T (p.H229Y) alteration is located in exon 6 (coding exon 5) of the FNDC3B gene. This alteration results from a C to T substitution at nucleotide position 685, causing the histidine (H) at amino acid position 229 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at